| Effect of Taurine Supplementation on 20-km Self-Paced Cycling Performance in the Heat | Effect of Taurine Supplementation on 20-km Self-Paced Cycling Performance of Trained Cyclists in the Heat | ACTRN12625000520437 |
| Taurine's Therapeutic Effect on Acute Radiation-induced Oral Mucositis and Dermatitis | A Randomized Controlled Trial on Taurine's Therapeutic Effect on Acute Radiation-induced Oral Mucositis and Dermatitis | NCT07029178 |
| Effects of Taurine on treatment process of ulcerative colitis patients. | Effects of Taurine on clinical symptoms and laboratory parameters of ulcerative colitis patients. | IRCT201101275704N1 |
| Effect of taurine in reducing acute kidney injury | Upregulating Heme Oxygenase-1 by Taurine to reduce Acute Kidney Injury in cardiac surgery: a phase II randomised controlled trial (the HOT-AKI trial) - the HOT-AKI trial | ChiCTR2500102159 |
| Effect of combination of Taurine, N-Acetyl Cysteine and Coenzyme Q10 (Uralbu TM) on uACR in Diabetic Patients | Safety and Efficacy of a fixed dose combination of Taurine, N-Acetyl Cysteine and Coenzyme Q10 (Uralbu TM) on Microalbuminuria in Type II Diabetic Patients: A Randomized Controlled, Double-Blind Trial - NIL | CTRI/2025/04/084293 |
| Effect of Acute Supplementation (taurine) on Maximal Strength and Anaerobic Power | Effect of Acute Supplementation (taurine) on Maximal Strength and Anaerobic Power | NCT06884566 |
| Effects of taurine consumption on the physical performance of professional soccer players | Effects of acute Taurine consumption on physical performance parameters in professional soccer athletes: a triple-blind, randomized, crossover clinical trial | RBR-10mdc4h7 |
| Taurine Or Placebo for Healthcare Workers: the TOP Healthcare workers' Bayesian Optimized Phase II randomised-controlled trial | Taurine Or Placebo for Healthcare Workers: the TOP Healthcare workers' Bayesian Optimized Phase II randomised-controlled trial | ChiCTR2500102879 |
| Development of oral taurine therapy for the treatment of stroke-like epiodes of MELAS | Development of oral taurine therapy for the treatment of stroke-like epiodes of MELAS - Taurine therapy for stroke-like epiodes of MELAS | JPRN-UMIN000005592 |
| Oral Supplementation with Taurine for Patients with Cirrhosis and Muscle Cramps | Does Oral Supplementation with Taurine for Patients with Cirrhosis and Muscle Cramps Reduce the Severity and Frequency of Muscle Cramps? | ACTRN12612000289819 |
| Clinical Trial on the Effects of Caffeine and Taurine From Energy Drinks (EDs) to Parameters of the Cardiovascular System in Humans | | NCT01421979 |
| Taurine Supplementation on Cognitive Function in Patients With Diabetes | A Randomized, Double-blind, Placebo Controlled Clinical Trial Comparing Effects of Taurine Supplementation on Cognitive Function in Patients With Diabetes | NCT03410173 |
| Taurine Supplementation on Lower Extremity Vasculopathy in Patients With Diabetes | A Randomized, Double-blind, Placebo Controlled Clinical Trial Comparing Effects of Taurine Supplementation on Lower Extremity Vasculopathy in Patients With Diabetes | NCT03410537 |
| effects of taurine in traumatic brain injury | Effects of Taurine Powder Supplementation on Inflammatory Markers and Clinical Outcomes in Traumatic Brain Injury Patients Admitted to the Intensive Care Unit | IRCT20180514039657N1 |
| Safety follow-up survey for MELAS taurine high-dose therapy subjects after completion of doctor-initiated clinical trial | Safety follow-up survey for MELAS taurine high-dose therapy subjects after completion of doctor-initiated clinical trial - Safety follow-up survey for MELAS taurine high-dose therapy subjects | JPRN-UMIN000029376 |
| Efficacy and Safety of Creatine/Taurine for Relieving Stress and Tension | Efficacy and Safety of Creatine/Taurine for Relieving Stress and Tension: A Prospective Randomized Double-Blind Placebo-Controlled Clinical Trial | KCT0003101 |
| Clinical Merit of A Functional Nutrient | Safety and efficacy of a functional nutrient of taurine as an add-on therapy to tiapride in the youngsters with tic disorders: a randomized, double-blind, placebo-controlled trial | ChiCTR1800018269 |
| Effect of Taurine Supplementation on Levels of Liver Antioxidants. | Comparison of the effect of Taurine supplementation on liver antioxidant levels during a period of endurance activity in endurance athletes | IRCT2017052128429N3 |
| Effect of Taurine in obesity | Evaluation of the effect of oral taurine supplementation on Serum levels of fibroblast growth factors ( FGF19, FGF21), ß-Klotho co-receptor, glycemic status, lipid profile, adipocytokines, hs-CRP and body composition in obese women on a weight-loss diet | IRCT20131125015542N2 |
| Low Protein Diet Supplementation Study in Non-Diabetic Kidney Disease Patients | A Randomized, Open Label, Three Arm, Comparative, Controlled, Single-center Study to Evaluate the Effect of Low Protein Diet Supplementation with Taurine and N-Acetylcysteine (Tab. Nefrosave) and N-Acetylcysteine and Pyridoxamine Dihydrochloride (Tab. Nefrosave Forte) in Preventing Progression of Chronic Renal Failure in Patients with Non-Diabetic Kidney Disease. | CTRI/2017/03/008246 |
| A multicentre, long-term trial of KN01 in patients with MELAS | A multicentre, long-term trial of KN01 in patients with MELAS - Long-term taurine-MELAS study | JPRN-UMIN000019195 |
| A multicentre, long-term administration study of KN01 in patients with mitochondrial encephalomyopathy(MELAS) | A multicentre, long-term administration study of KN01 in patients with mitochondrial encephalomyopathy(MELAS) - MELAS-taurine long-term study | JPRN-UMIN000015538 |
| Efficacy of enteral nutrition with commercial formula and Taurine Supplementation on Clinical outcome and nutritional status of Critically Ill burned patients in burned intensive care unit | Efficacy of enteral nutrition with commercial formula and Taurine Supplementation on Clinical outcome and nutritional status of Critically ill burned patients in burned intensive care unit | IRCT201307082017N13 |
| A multicentre trial of KN01 in patients with mitochondrial encephalomyopathy (MELAS) | A multicentre trial of KN01 in patients with mitochondrial encephalomyopathy (MELAS) - MELAS-taurine study | JPRN-UMIN000011908 |
| Role Of Energy drinks in alertness. | Effects of Taurine on systemic Inflammation and cognitive function following acute sleep deprivation | CTRI/2013/03/003512 |
| Effects and Safety of Taurine Granule on Blood Pressure in Prehypertensive | A Randomized, Double-Blind, Placebo Control Trial Comparing Effects and Safety of TAURINE GRANULE and Placebo on Blood Pressure in Prehypertensive. | NCT01816698 |
| Development of oral taurine therapy for the treatment of MERRF | Development of oral taurine therapy for the treatment of MERRF - Taurine therapy for MERRF | JPRN-UMIN000009358 |
| Safety follow-up survey for MELAS taurine high-dose therapy subjects | Safety follow-up survey for MELAS taurine high-dose therapy subjects after completion of doctor-initiated clinical trial - Safety follow-up survey for MELAS taurine high-dose therapy subjects | JPRN-jRCTs061180015 |
| A clinical trial to study the effects of RTFIT Tablets (Racemethionine 200 mg + Taurine 500 mg Tablets) in patients with alcoholic liver disease. | A Randomized, Open Label, Parallel Group, Placebo-controlled, Efficacy and Safety Study of RTFIT Tablets in patients with alcoholic liver disease. - Nil | CTRI/2011/05/001764 |
| Effects of Taurine Supplementation on Repetitive Sprint Performance and Exhaustion Time in College Students Under High-Temperature and High-Humidity Conditions | Effects of Taurine Supplementation on Repetitive Sprint Performance and Exhaustion Time in College Students Under High-Temperature and High-Humidity Conditions | NCT06824571 |
| Effects Of Daily Taurine Intake For 6 Months On Biological Age and Body Metabolism Indicators As Well As Physical Fitness In 55-75-year-old Women And Men | Effect Of Daily Taurine Supplementation For 6 Months On Biological Age and Metabolic Biomarkers As Well As Physical Fitness In 55-75-year-old Women And Men: A Randomized Controlled Intervention Study | NCT06613542 |
| Taurine Eye Drops May Prevent the Progression of Cataract | Taurine Affects the Progression of Senile Cataract: a Single-arm Pre-post Intervention Study | NCT06639711 |
| Thalassemic Iron Overload Cardiomyopathy is Ameliorated by Taurine Supplementation | Thalassemic Iron Overload Cardiomyopathy is Ameliorated by Taurine Supplementation (TICATS Study) | NCT04291352 |
| Effect of Taurine in treatment of diabetes | The effects of taurine supplementation on serum levels of endothelial markers, metabolic parameters, adipokines, inflammatory and glycemic indicators and nutritional status in patients with type 2 diabetes | IRCT20180712040438N3 |
| Efficacy and safety of taurine supplementation in A3243G-maternally-inherited diabetes and deafness | A multicentre, double-blind, placebo-controlled randomized controlled trial of KN01 in patients with A3243G-maternally-inherited diabetes and deafness | JPRN-jRCT2061190026 |
| TAURINE and HCC PATIENTS | COMPARISON BETWEEN SERUM TAURINE AND SPECIFIC TUMOR MARKERS FOR EARLY DETECTION AND DIAGNOSIS OF HCC IN EGYPTIAN PATIENTS | NCT04193761 |
| The Effect of Taurine on Morbidity and Mortality in the Elderly Hip Fracture Patient | The Effect of Taurine on Morbidity and Mortality in the Elderly Hip Fracture Patient - TAUrine & hip fracture Patient (TAUP-Study) | NL-OMON37158 |
| The Effect of Taurine on Morbidity and Mortality in the Elderly Hip Fracture Patient | The Effect of Taurine on Morbidity and Mortality in the Elderly Hip Fracture Patient | NCT00497978 |
| Taurine and painful diabetic neuropathy | Taurine and painful diabetic neuropathy | ISRCTN49416618 |
| Ensayo Clínico fase IV, prospectivo, aleatorizado, doble ciego, de grupos paralelos y unicéntrico, para evaluar el efecto de la taurina en Nutrición Parenteral Total sobre la función hepática en pacientes postquirúrgicos. Clinical Trial phase IV, prospective, randomized, double blind, of parallel groups and unicentric, to evaluate the effect of taurine in total parenteral nutrition on the hepatic function in post surgical patients. - GRITAU | Ensayo Clínico fase IV, prospectivo, aleatorizado, doble ciego, de grupos paralelos y unicéntrico, para evaluar el efecto de la taurina en Nutrición Parenteral Total sobre la función hepática en pacientes postquirúrgicos. Clinical Trial phase IV, prospective, randomized, double blind, of parallel groups and unicentric, to evaluate the effect of taurine in total parenteral nutrition on the hepatic function in post surgical patients. - GRITAU | EUCTR2009-009918-40-ES |
| Oxidative Stress Markers In Inherited Homocystinuria And The Impact Of Taurine | Oxidative Stress Markers In Inherited Homocystinuria And The Impact Of Taurine | NCT01192828 |
| The Prospect of Using Serum Taurine Level as a Potential Biomarker for Early Detection of Colorectal Carcinoma and Its Correlation With Other Prognostic Markers | The Prospect of Using Serum Taurine Level as a Potential Biomarker for Early Detection of Colorectal Carcinoma and Its Correlation With Other Prognostic Markers | NCT04192539 |
| The impact of oral ahiflower oil and taurine intake on omega-3 fatty acid status and cardiovascular risk in humans. | The impact of oral ahiflower oil and taurine intake on omega-3 fatty acid status and cardiovascular risk in humans. - Omega-Top | DRKS00018872 |
| Protective effects of taurine against MTX, gentamicin and carbamazepin's toxicity | Study of the protective effects of taurine against drug-induced toxicity in the patients treated by MTX, gentamicin and carbamazepin | IRCT138812123482N1 |
| Taurine Supplementation and Training Effects on Energy Metabolism, Inflammation and Oxidative Stress in Obese Women | Taurine Supplementation and Physical Training Effects on Adipose Tissue Mitochondrial Energy Metabolism, and Blood Inflammation and Oxidative Stress in Obese Women | NCT04279600 |
| Effect of Taurine on Glycemic Control in Type I and Type II Diabetic Patients | Effect of Taurine on Glycemic Control in Type I and Type II Diabetic Patients | NCT01226537 |
| Evaluation of Serum Taurine as a Prognostic Marker for Graft Function in Adult Egyptian Patients Undergoing Living Donor Liver Transplant | Evaluation of Serum Taurine as a Prognostic Marker for Graft Function in Adult Egyptian Patients Undergoing Living Donor Liver Transplant : A Prospective Study | NCT04047043 |
| Effect of Taurine or Bitter Melon Extracts Supplementation on Energy Metabolism during Exercise | Effect of Taurine or Bitter Melon Extracts Supplementation on Energy Metabolism during Exercise - Effect of Taurine or Bitter Melon Extracts Supplementation on Energy Metabolism during Exercise | JPRN-UMIN000036696 |
| Taurine in Peripartum Cardiomyopathy | Taurine for Early Left Ventricular Recovery in Peripartum Cardiomyopathy | NCT03907267 |
| taurine in diabetes | The effects of taurine supplementation on serum levels of pentosidine, soluble receptor of advanced glycation end products, methylglyoxal, glycemic, oxidative and nutritional status in patients with type 2 diabetes | IRCT20121028011288N17 |
| Taurine in type 2 diabetes | The effect of taurine supplementation on serum levels of adiponectin, irisin, fibroblast growth factor-21, sirtuin-1, metabolic parameters, oxidative, inflammatory indicators and nutritional status in patients with type 2 diabetes | IRCT20121028011288N16 |
| A Study of Taurine in Patients With First-episode Psychosis Receiving Antipsychotic Treatment | A 12-week, Parallel, Double-blind, Randomised, Placebo-controlled Adjunctive Study of Taurine 4 Grams in 128 Patients With First-episode Psychosis Receiving Antipsychotic Treatment. | NCT00420823 |
| A multi-site trial of a novel nutritional supplement (taurine, omega-3 fatty acids, zinc, antioxidants, and lutein) and micro-current stimulation in the treatment of atrophic (dry) age-related macular degeneration | | ISRCTN57556290 |
| Effect of omega-3 and taurine on muscle damage indices | Comparing four-week taurine and omega-3 consumption and simultaneous consumption of both nutrients on muscle damage indices after eccentric resistance exercise | IRCT20200327046871N1 |
| Taurine in Adolescents With Bipolar Disorder | Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study in Adolescents With Bipolar Disorder | NCT00391001 |
| Effect of daily taurine supplementation for 6 months on age and metabolic biomarkers as well as physical fitness in 55-75-year-old women and men:the TauAge Study | Effect of daily taurine supplementation for 6 months on age and metabolic biomarkers as well as physical fitness in 55-75-year-old women and men:the TauAge Study - TauAge | DRKS00035066 |
| Clinical Study of Taurine Combined With Neoadjuvant Chemo-Immunotherapy for Treatment of Locally Advanced Gastric Cancer | A Prospective, Multicentre, Double-blind Randomized Controlled Clinical Study of the Efficacy and Safety of Taurine Combined With Serplulimab and Chemotherapy Versus Serplulimab Combined With Chemotherapy for Treatment of Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma | NCT06128252 |
| Clinical Study of Taurine Combined With Sintilimab and Chemotherapy for Treatment of Advanced Gastric Cancer | A Prospective, Randomized Controlled Clinical Study of The Efficacy and Safety of Taurine Combined With Sintilimab and Chemotherapy Versus Sintilimab Combined With Chemotherapy for Treatment of Advanced Gastric Cancer | NCT06123455 |
| Study on the Treatment of Taurine in Children With Autism | Taurine Supplementation Improves Core Symptoms in Children With Autism Spectrum Disorders: an Exploratory Randomized, Double-blinded, Controlled Trial | NCT05980520 |
| The effect of taurine in reducing the incidence of ventilator-associated pneumonia | Evaluating the effectiveness of taurine in reducing the incidence of ventilator-associated pneumonia inchildren undergoing mechanical ventilation in the pediatric intensive care unit of Shiraz Namazi Hospital arandomized, double-blind clinical trial | IRCT20120731010453N4 |
| A clinical trial to study the effect of a drug, L-Taurine, for fatigue in patients with advanced liver disease | L-Taurine for fatigue in decompensated cirrhosis: a randomized controlled trial - NIL | CTRI/2023/06/054455 |
| A multicenter, prospective, real-world study on the efficacy and safety of taurine ursodeoxycholic acid capsule in the treatment of dyspepsia complications after cholecystectomy in patients with gallstones | A multicenter, prospective, real-world study on the efficacy and safety of taurine ursodeoxycholic acid capsule in the treatment of dyspepsia complications after cholecystectomy in patients with gallstones | ChiCTR2300069942 |
| Preventive effect of taurine drug on liver transplant recipients | The protective Effect of taurine on Ischemia-reperfusion syndrom Following liver transplantation | IRCT20120731010453N3 |
| Effect of 4 Weeks Supplementation of a Combination of Vitamin Bs and Taurine on Mental Performance in Healthy Adults | Effect of 4 Weeks Supplementation of a Combination of Vitamin Bs and Taurine on Mental Performance in Healthy Adults | NCT05733364 |
| Taurine Supplementation in Long COVID | Taurine Supplementation as a Novel Therapeutic Approach for Neurocognitive Symptoms in Long COVID | NCT06721949 |
| Taurine Supplementation Associated or Not With Exercise: Effect on Browning of White Adipose Tissue in Elderly Women With Sarcopenic Obesity | Taurine Supplementation Associated or Not With Exercise: Effect on Browning of White Adipose Tissue in Elderly Women With Sarcopenic Obesity | NCT05415176 |
| Taurine as a Possible Anti-aging Therapy? | Taurine as a Possible Anti-aging Therapy? A Controlled Clinical Trial on Taurine Antioxidant Activity in Women Aged 55 to 70 Years | NCT05149716 |
| Taurine Effect on Glycemic, Lipidic and Inflammatory Profile in Individuals with Type 2 Diabetes | Effect of Taurine on Glycemic, Lipid and Inflammatory Profile in Individuals with Type 2 Diabetes: a Randomized Clinical Trial | NCT04874012 |
| Effect of Amnion Membrane With and Without Taurine on GCF TNF a Level. | Efficacy of Subgingivally Placed Amnion Membrane With and Without Taurine as an Adjunct to Scaling and Root Planing in the Treatment of Chronic Periodontitis | NCT04772508 |
| Taurine Supplementation and Exercise on Irisin Levels in Obesity | Effects of Taurine Supplementation Associated With High Intensity Physical Training on Irisin Levels, Energy Expenditure and Body Composition of Obese Women | NCT04646512 |
| The anti-endotoxin agent, taurolidine, potentially reduces ischaemia-reperfusion injury through its metabolite taurine | An investigation into the efficacy of the anti-endotoxin agent, taurolidine in the attenuation of the post-reperfusion sequelae in patients subjected to cardio-pulmonary bypass: a double-blinded randomised clinical trial | ISRCTN58678663 |
| Effect of taurine in liver transplantation | Evaluation of the effect of taurine on graft function in post-liver transplant recipients, a double-blind clinical trial | IRCT20200312046755N1 |
| Effect of Taurine on Physiologic and functional changes in patients with Cardiac heart failure | Physiological and Functional Changes after the short term Taurine Supplementation in patient with Cardiac Heart Failure Complication | IRCT138903094058N1 |
| Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study | Taurine as an Anti-manic Agent: a Double-blind Placebo-controlled Study. | NCT00217165 |
| A Trial of Taurine Supplementation in Parenteral Nutrition 1 | A Randomised Double Blind Controlled Crossover Trial of Intravenous Taurine Supplementation in Parenteral Nutrition as an Effective Treatment for Reducing Hepatobiliary Complications in Chronic Intestinal Failure | NCT00135044 |
| The effect of Taurine on cognitive and physical function | Acute effects of low and high doses of Taurine on physical and cognitive functions in 60-69 years old men | IRCT20170326033146N7 |
| Taurine and Painful Diabetic Neuropathy | Taurine and Painful Diabetic Neuropathy | EUCTR2005-004196-37-GB |
| Effects of a PF Ophthalmic Solution Containing HA0.4% and TAU 0.5% | Exploring the Effects of a Preservative-free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-term Topical Hypotensive Therapy | NCT03480295 |
| A clinical trial to study the effect of a drug,Taurine in Subjects having traumatic Spinal cord INJURY | Role of Taurine Supplementation in Neurological Recovery of Acute Spinal Cord Injury (ASCI) Subjects: A Non Randomized Control Clinical Trial | CTRI/2022/11/047262 |
| Research on Taurine and L-Carnitine supplements for relief of muscle cramps in patients with liver cirrhosis | A double-blind Randomized control trial to study the efficacy of combination of Taurine and L-Carnitine in alleviating muscle cramps in patients with liver cirrhosis. | CTRI/2025/06/088418 |
